ALLMedicine™ Addiction Center

Sep 26th, 2021 - Buprenorphine/naloxone is an effective medication for the treatment of opioid use disorder. Unlike methadone, which can only be dispensed in federally waived clinics and which must be combined with specific psychosocial treatment, buprenorphine ca...

Sep 26th, 2021 - Alcohol use disorder (AUD) is a common illness with significant health and economic consequences. Although three pharmacotherapeutic agents have been shown to decrease heavy drinking days among individuals with AUD, they are vastly underutilized i...

Sep 26th, 2021 - The study was conducted descriptively to determine the social media addiction, cyberbullying (CB) and cyber victimization (CV) of health sciences faculty students. 518 students who volunteered to participate in the study from among the students st...

Sep 25th, 2021 - Non-small-cell lung cancer (NSCLC) is one of the most common and deadly cancers. Several molecular drivers of oncogene addiction are now known to be strong predictive biomarkers for target therapies. Advances in large Next Generation Sequencing (L...

Sep 25th, 2021 - Addiction is a complex condition and a brain disease manifested by compulsive substance use despite its harmful consequence. Addicted individuals have an intense focus on using substances. This study aimed to investigate the effect of adding meman...

Jan 25th, 2021 - Opioid-related morbidity and mortality have risen in many settings globally. It is critical that practitioners who work with adolescents and young adults (AYAs) provide timely, evidence-based treatment for opioid use disorder (OUD). Such treatment...

Sep 11th, 2020 - : The American Society of Addiction Medicine (ASAM) Clinical Practice Guideline on Alcohol Withdrawal Management provides guidance on the identification and management of alcohol withdrawal in adults with varying degrees of syndrome severity. The ...

Mar 27th, 2020 - : A Focused Update of the ASAM National Practice Guideline for the Treatment of Opioid Use Disorder is published in the current issue of the Journal of Addiction Medicine. The focused update included a search of Medline's PubMed database from Janu...

Apr 1st, 2019 - Substance use disorders in pregnancy: clinical, ethical, and research imperatives of the opioid epidemic: a report of a joint workshop of the Society for Maternal-Fetal Medicine, American College of Obstetricians and Gynecologists, and American So...

Sep 29th, 2018 - In 2016, there were 44.7 million adults affected by mental illness, and 20.1 million people aged 12 years or older affected by substance use disorder. More than 8.2 million Americans are afflicted with co-occurring disorders or dual diagnosis, suc...

Oct 5th, 2018 - Patients admitted with active IE secondary to IV drug use require a myriad of services and will remain hospitalized for a minimum of six weeks. During their hospitalization, infectious disease service assists in developing a treatment plan for the...

Jul 16th, 2021 - Administering high-dose buprenorphine in the emergency department (ED) to individuals with untreated opioid use disorder (OUD) is safe, well tolerated, and may help get more patients into treatment after discharge. "Emergency departments are at th...

Jul 15th, 2021 - "There are no interventions that have been shown to be effective in attaining viral suppression in people who inject drugs (PWID)," 2021 HIV/AIDS Research Avenir Award winner Hansel Tookes, MD, infectious disease specialist at the University of Mi...

Jul 8th, 2021 - PROVIDENCE, R.I. (AP) — Rhode Island's governor has signed into law a bill authorizing the opening of so-called harm reduction centers where people dealing with addiction can take heroin and other illegal drugs under the supervision of medical pro...

Jul 2nd, 2021 - PROVIDENCE, R.I. (AP) — Rhode Island is poised to become the first state to authorize so-called harm reduction centers where people dealing with addiction can take heroin and other illegal drugs under the supervision of medical professionals. Legi...

Jul 2nd, 2021 - In his multiple attempts to overcome a methamphetamine addiction that ground through two decades of his life, Tyrone Clifford Jr. remembers well the closest he came. "The most success I had," he said, "is when my dealer was in jail." Then Clifford...